-
Je něco špatně v tomto záznamu ?
Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease
K. Veverová, J. Laczó, A. Katonová, H. Horáková, V. Matušková, F. Angelucci, M. Laczó, Z. Nedelská, J. Hort, HL. Wang, J. Zhang, L. Shi, E. Fei Fang, M. Vyhnálek
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2005 do Před 1 rokem
PubMed Central
od 2006 do Před 1 rokem
Europe PubMed Central
od 2008 do Před 1 rokem
- MeSH
- Alzheimerova nemoc * mozkomíšní mok krev diagnóza MeSH
- biologické markery * mozkomíšní mok krev metabolismus MeSH
- kognitivní dysfunkce mozkomíšní mok krev diagnóza MeSH
- lidé středního věku MeSH
- lidé MeSH
- membránové proteiny mozkomíšní mok metabolismus krev MeSH
- mitofagie * MeSH
- mozek metabolismus patologie MeSH
- nádorové supresorové proteiny MeSH
- proteinkinasy metabolismus MeSH
- proteiny tau mozkomíšní mok metabolismus MeSH
- protoonkogenní proteiny mozkomíšní mok krev metabolismus MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- transkripční faktory BHLH-Zip metabolismus MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Defective mitophagy is consistently found in postmortem brain and iPSC-derived neurons from Alzheimer disease (AD) patients. However, there is a lack of extensive examination of mitophagy status in serum or cerebrospinal fluid (CSF), and the clinical potential of mitophagy biomarkers has not been tested. We quantified biomarkers of mitophagy/autophagy and lysosomal degradation (PINK1, BNIP3L and TFEB) in CSF and serum from 246 individuals, covering mild cognitive impairment due to AD (MCI-AD, n = 100), dementia due to AD (AD-dementia, n = 100), and cognitively unimpaired individuals (CU, n = 46), recruited from the Czech Brain Aging Study. Cognitive function and brain atrophy were also assessed. Our data show that serum and CSF PINK1 and serum BNIP3L were higher, and serum TFEB was lower in individuals with AD than in corresponding CU individuals. Additionally, the magnitude of mitophagy impairment correlated with the severity of clinical indicators in AD patients. Specifically, levels of PINK1 positively correlated with phosphorylated (p)-MAPT/tau (181), total (t)-MAPT/tau, NEFL (neurofilament light chain), and NRGN (neurogranin) levels in CSF and negatively with memory, executive function, and language domain. Serum TFEB levels negatively correlated with NEFL and positively with executive function and language. This study reveals mitophagy impairment reflected in biofluid biomarkers of individuals with AD and associated with more advanced AD pathology.Abbreviation: Aβ: amyloid beta; AD: Alzheimer disease; AVs: autophagic vacuoles; BNIP3L: BCL2 interacting protein 3 like; CU: cognitively unimpaired; CSF: cerebrospinal fluid; LAMP1: lysosomal-associated membrane protein 1; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MCI: mild cognitive impairment; NRGN: neurogranin; NEFL: neurofilament light chain; p-MAPT/tau: phosphorylated microtubule associated protein tau; PINK1: PTEN induced kinase 1; t-MAPT/tau: total microtubule associated protein tau; TFEB: transcription factor EB; TMT: Trail Making Test.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019588
- 003
- CZ-PrNML
- 005
- 20241024110636.0
- 007
- ta
- 008
- 241015s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/15548627.2024.2340408 $2 doi
- 035 __
- $a (PubMed)38695174
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Veverová, Kateřina $u Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000258451854
- 245 10
- $a Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease / $c K. Veverová, J. Laczó, A. Katonová, H. Horáková, V. Matušková, F. Angelucci, M. Laczó, Z. Nedelská, J. Hort, HL. Wang, J. Zhang, L. Shi, E. Fei Fang, M. Vyhnálek
- 520 9_
- $a Defective mitophagy is consistently found in postmortem brain and iPSC-derived neurons from Alzheimer disease (AD) patients. However, there is a lack of extensive examination of mitophagy status in serum or cerebrospinal fluid (CSF), and the clinical potential of mitophagy biomarkers has not been tested. We quantified biomarkers of mitophagy/autophagy and lysosomal degradation (PINK1, BNIP3L and TFEB) in CSF and serum from 246 individuals, covering mild cognitive impairment due to AD (MCI-AD, n = 100), dementia due to AD (AD-dementia, n = 100), and cognitively unimpaired individuals (CU, n = 46), recruited from the Czech Brain Aging Study. Cognitive function and brain atrophy were also assessed. Our data show that serum and CSF PINK1 and serum BNIP3L were higher, and serum TFEB was lower in individuals with AD than in corresponding CU individuals. Additionally, the magnitude of mitophagy impairment correlated with the severity of clinical indicators in AD patients. Specifically, levels of PINK1 positively correlated with phosphorylated (p)-MAPT/tau (181), total (t)-MAPT/tau, NEFL (neurofilament light chain), and NRGN (neurogranin) levels in CSF and negatively with memory, executive function, and language domain. Serum TFEB levels negatively correlated with NEFL and positively with executive function and language. This study reveals mitophagy impairment reflected in biofluid biomarkers of individuals with AD and associated with more advanced AD pathology.Abbreviation: Aβ: amyloid beta; AD: Alzheimer disease; AVs: autophagic vacuoles; BNIP3L: BCL2 interacting protein 3 like; CU: cognitively unimpaired; CSF: cerebrospinal fluid; LAMP1: lysosomal-associated membrane protein 1; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MCI: mild cognitive impairment; NRGN: neurogranin; NEFL: neurofilament light chain; p-MAPT/tau: phosphorylated microtubule associated protein tau; PINK1: PTEN induced kinase 1; t-MAPT/tau: total microtubule associated protein tau; TFEB: transcription factor EB; TMT: Trail Making Test.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a Alzheimerova nemoc $x mozkomíšní mok $x krev $x diagnóza $7 D000544
- 650 12
- $a mitofagie $7 D063306
- 650 12
- $a biologické markery $x mozkomíšní mok $x krev $x metabolismus $7 D015415
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a membránové proteiny $x mozkomíšní mok $x metabolismus $x krev $7 D008565
- 650 _2
- $a kognitivní dysfunkce $x mozkomíšní mok $x krev $x diagnóza $7 D060825
- 650 _2
- $a proteinkinasy $x metabolismus $7 D011494
- 650 _2
- $a protoonkogenní proteiny $x mozkomíšní mok $x krev $x metabolismus $7 D011518
- 650 _2
- $a mozek $x metabolismus $x patologie $7 D001921
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a proteiny tau $x mozkomíšní mok $x metabolismus $7 D016875
- 650 _2
- $a transkripční faktory BHLH-Zip $x metabolismus $7 D051778
- 650 _2
- $a nádorové supresorové proteiny $7 D025521
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Laczó, Jan $u Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Katonová, Alžběta $u Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Horáková, Hana $u Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Matušková, Veronika $u Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Angelucci, Francesco $u Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Laczó, Martina $u Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Nedelská, Zuzana $u Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Hort, Jakub $u Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Wang, He-Ling $u Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway
- 700 1_
- $a Zhang, Jianying $u Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway
- 700 1_
- $a Shi, Liu $u Department of Psychiatry, University of Oxford, Oxford, UK
- 700 1_
- $a Fei Fang, Evandro $u Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway $u The Norwegian Centre on Healthy Ageing (NO-Age), Oslo, Norway
- 700 1_
- $a Vyhnálek, Martin $u Memory Clinic, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000259764932 $7 xx0070891
- 773 0_
- $w MED00184413 $t Autophagy $x 1554-8635 $g Roč. 20, č. 8 (2024), s. 1868-1878
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38695174 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024110630 $b ABA008
- 999 __
- $a ok $b bmc $g 2202054 $s 1231561
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 20 $c 8 $d 1868-1878 $e 20240502 $i 1554-8635 $m Autophagy $n Autophagy $x MED00184413
- LZP __
- $a Pubmed-20241015
